JRS Pharma

Company Overview
JRS Pharma produces excipient technologies and products that enable pharmaceutical and biotech companies to develop high-quality tablets and capsules with significant cost savings. PROSOLV, a high-functionality excipient, delivers outstanding flow, compaction and drug dispersion simultaneously to tablet formulations. This enables development of cost-effective, direct compression formulas that produce distinct, smaller tablets with measurable content uniformity. The JRS product line also includes EMCOCEL, VIVAPUR and other insoluble tablet binders; soluble binders EMDEX and SUGARTAB; EXPLOTAB, VIVASOL and other disintegrants; and lubricants PRUV and LUBRITAB.

Quick Facts
JRS Pharma
2981 Route 22, Suite 1
Patterson, NY 12563

Featured Solutions

• Roller compaction studies and granule characteristics of silicified ... by JRS Pharma
  This white paper by JRS Pharma LP discusses roller compaction studies and granule characteristics, and investigates the similarity between silicified microcrystalline cellulose (SMCC) and microcrystalline cellulose (MCC).
  
  
• Stable Thyroid harmone preparations and method of making same by JRS Pharma
  This white paper by JRS Pharma LP, explains a stable thyroid hormone preparation, which can be readily formed into dosage formulation.
  
  
• Excipio economics: A new approach for improving the efficiency of oral dosage... by JRS Pharma
  This white paper by JRS Pharma LP discusses a new approach, called excipio economics, to evaluating the economic impact of new excipients on the development and manufacturing of tablets.
  
  
• The preparation of pellets with silicified microcrystalline cellulose by ... by JRS Pharma
  This paper by JRS Pharma LP explains the preparation of pellets with the excipient silicified microcrystalline cellulose (SMCC) by extrusion and spheronization.